Revolution Medicines, Inc.
RVMD
$203.71
$1.710.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M |
| Total Depreciation and Amortization | 4.50M | 4.54M | 4.60M | 4.04M | 3.60M |
| Total Amortization of Deferred Charges | -- | -- | 100.00K | 300.00K | 200.00K |
| Total Other Non-Cash Items | 237.48M | 112.06M | 53.71M | 37.11M | 26.53M |
| Change in Net Operating Assets | 15.08M | -16.95M | 32.25M | 56.44M | -4.30M |
| Cash from Operations | -387.32M | -354.17M | -274.24M | -207.31M | -221.76M |
| Capital Expenditure | -2.29M | -1.54M | -1.93M | -3.35M | -7.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.66B | 174.15M | 76.81M | 28.20M | 41.73M |
| Cash from Investing | -1.66B | 172.62M | 74.88M | 24.85M | 34.28M |
| Total Debt Issued | 487.07M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.69B | 239.00M | 365.47M | 4.15M | 6.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 244.51M | -252.00K | 191.00K | -5.74M | 250.00M |
| Cash from Financing | 2.42B | 238.74M | 365.66M | -1.59M | 256.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 374.50M | 57.19M | 166.30M | -184.05M | 69.10M |